ArticleTherapeutic advances in medical oncology2021
Erratum to "Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.